Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells

The present study investigated the terminal differentiation capacity into adipocytes and subsequent growth inhibition in A549 cancer cells treated with pioglitazone (PGZ), a PPARγ activator. The rate of cell growth in A549 cells was significantly (P < .05) inhibited in concentrations above 10 μM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Anim Cells Syst (Seoul)
Main Authors: Kim, Dae-Young, Moon, Sun-Ha, Han, Jang-Ho, Kim, Mi-Jeong, Oh, Seong-Ju, Bharti, Dinesh, Lee, Sung-Ho, Park, Jong-Kuen, Rho, Gyu-Jin, Jeon, Byeong-Gyun
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Developmental Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781920/
https://ncbi.nlm.nih.gov/pubmed/33456717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19768354.2020.1847731
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados